US Stock MarketDetailed Quotes

Emergent BioSolutions (EBS)

Watchlist

9.050
+0.510+5.97%

Close May 5 15:59 ET

9.000
-0.050-0.55%

Pre 05:09 ET

466.95MMarket Cap-47.63P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Emergent BioSolutions (EBS) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-201.79%-33.8M

190.63%170.6M

197.25%77.7M

-101.50%-2.3M

124.00%106.4M

82.11%-11.2M

128.45%58.7M

-348.91%-79.9M

156.17%153.7M

141.52%47.5M

Net income from continuing operations

-90.00%6.8M

127.60%52.6M

-74.44%-54.6M

-55.40%51.2M

95.76%-12M

655.56%68M

74.94%-190.6M

36.77%-31.3M

143.58%114.8M

-8.30%-283.1M

Operating gains losses

-353.33%-7.6M

516.67%10M

-295.00%-3.9M

111.61%7M

--3.9M

--3M

95.48%-2.4M

-72.22%2M

-513.01%-60.3M

----

Depreciation and amortization

-7.48%23.5M

-11.95%95.8M

-9.62%23.5M

-11.36%23.4M

-17.54%23.5M

-8.96%25.4M

-13.03%108.8M

-12.16%26M

-5.71%26.4M

-13.37%28.5M

Deferred tax

-124.19%-4.5M

27.27%-4M

475.00%1.5M

-239.73%-10.2M

-6,850.00%-13.9M

252.46%18.6M

38.20%-5.5M

92.31%-400K

170.37%7.3M

88.24%-200K

Other non cash items

76.67%-2.1M

-29.66%10.2M

143.75%11.7M

220.83%2.9M

-41.03%4.6M

-309.30%-9M

8.21%14.5M

50.00%4.8M

75.76%-2.4M

-57.84%7.8M

Change In working capital

56.36%-51.8M

-125.25%-22.4M

196.13%82M

-224.09%-81.4M

-53.52%95.7M

-21.74%-118.7M

226.17%88.7M

-299.30%-85.3M

-0.30%65.6M

244.19%205.9M

-Change in receivables

46.93%-38.9M

204.51%25.5M

167.32%51.9M

-187.00%-71.6M

480.88%118.5M

-46.60%-73.3M

-12.96%-24.4M

-308.94%-77.1M

15.43%82.3M

115.41%20.4M

-Change in inventory

818.18%15.8M

-23.67%-30.3M

29.09%14.2M

2.22%-17.6M

-90.00%-24.7M

51.11%-2.2M

-4,183.33%-24.5M

-57.03%11M

-17,900.00%-18M

-324.14%-13M

-Change in prepaid assets

-105.26%-500K

-93.11%11.7M

-165.25%-15.4M

84.67%-2.1M

-88.13%19.7M

258.33%9.5M

1,352.14%169.9M

-21.33%23.6M

-2,640.00%-13.7M

1,348.12%166M

-Change in payables and accrued expense

18.75%-36.4M

7.71%-35.9M

183.63%32.7M

-43.75%1.8M

-181.01%-25.6M

-29.48%-44.8M

29.91%-38.9M

7.35%-39.1M

60.00%3.2M

532.88%31.6M

-Change in other working capital

203.80%8.2M

0.00%6.6M

62.16%-1.4M

-31.36%8.1M

766.67%7.8M

-229.17%-7.9M

220.00%6.6M

50.67%-3.7M

271.01%11.8M

-79.55%900K

Cash from discontinued investing activities

Operating cash flow

-201.79%-33.8M

190.63%170.6M

197.25%77.7M

-101.50%-2.3M

124.00%106.4M

82.11%-11.2M

128.45%58.7M

-348.91%-79.9M

156.17%153.7M

141.52%47.5M

Investing cash flow

Cash flow from continuing investing activities

-104.03%-2.4M

-44.57%69.4M

-113.64%-3.9M

-103.04%-3.4M

473.91%17.2M

650.93%59.5M

-41.03%125.2M

350.88%28.6M

692.59%112M

-101.79%-4.6M

Net PPE purchase and sale

-106.96%-2.4M

262.67%24.4M

-178.57%-3.9M

-288.89%-3.4M

39.13%-2.8M

419.44%34.5M

70.93%-15M

87.72%-1.4M

114.29%1.8M

63.20%-4.6M

Net business purchase and sale

----

--0

----

-59.22%110.2M

--0

--110.2M

----

Net other investing changes

----

50.00%45M

--0

--20M

--25M

576.19%30M

----

Cash from discontinued investing activities

Investing cash flow

-104.03%-2.4M

-44.57%69.4M

-113.64%-3.9M

-103.04%-3.4M

473.91%17.2M

650.93%59.5M

-41.03%125.2M

350.88%28.6M

692.59%112M

-101.79%-4.6M

Financing cash flow

Cash flow from continuing financing activities

-2,750.00%-11.4M

28.11%-136.6M

-22,880.00%-113.9M

91.18%-15.9M

87.43%-6.4M

-100.98%-400K

64.53%-190M

-89.36%500K

-319.30%-180.3M

89.55%-50.9M

Net issuance payments of debt

----

45.21%-108.7M

---101.8M

96.44%-6.9M

--0

63.49%-198.4M

--0

-352.21%-194M

90.83%-45.5M

Net common stock issuance

---9M

-367.74%-24.9M

---9.1M

-195.70%-8.9M

---6.9M

--0

10.71%9.3M

--0

--9.3M

----

Proceeds from stock option exercised by employees

300.00%400K

-85.23%2.2M

50.00%1.2M

-98.51%200K

0.00%700K

--100K

727.78%14.9M

60.00%800K

--13.4M

--700K

Net other financing activities

-460.00%-2.8M

67.09%-5.2M

-1,300.00%-4.2M

96.67%-300K

96.72%-200K

-25.00%-500K

-532.00%-15.8M

-200.00%-300K

-8,900.00%-9M

-2,950.00%-6.1M

Cash from discontinued financing activities

Financing cash flow

-2,750.00%-11.4M

28.11%-136.6M

-22,880.00%-113.9M

91.18%-15.9M

87.43%-6.4M

-100.98%-400K

64.53%-190M

-89.36%500K

-319.30%-180.3M

89.55%-50.9M

Net cash flow

Beginning cash position

98.01%209.1M

-5.46%105.6M

59.34%249.2M

281.69%271M

93.42%152.8M

-5.46%105.6M

-82.62%111.7M

78.13%156.4M

-19.86%71M

-81.64%79M

Current changes in cash

-199.37%-47.6M

1,795.08%103.4M

21.06%-40.1M

-125.29%-21.6M

1,565.00%117.2M

246.48%47.9M

98.85%-6.1M

-300.00%-50.8M

4,594.74%85.4M

97.67%-8M

Effect of exchange rate changes

--0

--100K

--0

---200K

--1M

---700K

--0

End cash Position

5.69%161.5M

98.01%209.1M

59.34%249.2M

281.69%271M

93.42%152.8M

-5.46%105.6M

78.13%156.4M

-19.86%71M

Free cash flow

-144.59%-36.2M

337.99%156.8M

190.44%73.8M

-103.85%-5.7M

141.26%103.5M

79.84%-14.8M

113.88%35.8M

-494.20%-81.6M

212.03%147.9M

133.81%42.9M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-201.79%-33.8M	190.63%170.6M	197.25%77.7M	-101.50%-2.3M	124.00%106.4M	82.11%-11.2M	128.45%58.7M	-348.91%-79.9M	156.17%153.7M	141.52%47.5M
Net income from continuing operations	-90.00%6.8M	127.60%52.6M	-74.44%-54.6M	-55.40%51.2M	95.76%-12M	655.56%68M	74.94%-190.6M	36.77%-31.3M	143.58%114.8M	-8.30%-283.1M
Operating gains losses	-353.33%-7.6M	516.67%10M	-295.00%-3.9M	111.61%7M	--3.9M	--3M	95.48%-2.4M	-72.22%2M	-513.01%-60.3M	----
Depreciation and amortization	-7.48%23.5M	-11.95%95.8M	-9.62%23.5M	-11.36%23.4M	-17.54%23.5M	-8.96%25.4M	-13.03%108.8M	-12.16%26M	-5.71%26.4M	-13.37%28.5M
Deferred tax	-124.19%-4.5M	27.27%-4M	475.00%1.5M	-239.73%-10.2M	-6,850.00%-13.9M	252.46%18.6M	38.20%-5.5M	92.31%-400K	170.37%7.3M	88.24%-200K
Other non cash items	76.67%-2.1M	-29.66%10.2M	143.75%11.7M	220.83%2.9M	-41.03%4.6M	-309.30%-9M	8.21%14.5M	50.00%4.8M	75.76%-2.4M	-57.84%7.8M
Change In working capital	56.36%-51.8M	-125.25%-22.4M	196.13%82M	-224.09%-81.4M	-53.52%95.7M	-21.74%-118.7M	226.17%88.7M	-299.30%-85.3M	-0.30%65.6M	244.19%205.9M
-Change in receivables	46.93%-38.9M	204.51%25.5M	167.32%51.9M	-187.00%-71.6M	480.88%118.5M	-46.60%-73.3M	-12.96%-24.4M	-308.94%-77.1M	15.43%82.3M	115.41%20.4M
-Change in inventory	818.18%15.8M	-23.67%-30.3M	29.09%14.2M	2.22%-17.6M	-90.00%-24.7M	51.11%-2.2M	-4,183.33%-24.5M	-57.03%11M	-17,900.00%-18M	-324.14%-13M
-Change in prepaid assets	-105.26%-500K	-93.11%11.7M	-165.25%-15.4M	84.67%-2.1M	-88.13%19.7M	258.33%9.5M	1,352.14%169.9M	-21.33%23.6M	-2,640.00%-13.7M	1,348.12%166M
-Change in payables and accrued expense	18.75%-36.4M	7.71%-35.9M	183.63%32.7M	-43.75%1.8M	-181.01%-25.6M	-29.48%-44.8M	29.91%-38.9M	7.35%-39.1M	60.00%3.2M	532.88%31.6M
-Change in other working capital	203.80%8.2M	0.00%6.6M	62.16%-1.4M	-31.36%8.1M	766.67%7.8M	-229.17%-7.9M	220.00%6.6M	50.67%-3.7M	271.01%11.8M	-79.55%900K
Cash from discontinued investing activities
Operating cash flow	-201.79%-33.8M	190.63%170.6M	197.25%77.7M	-101.50%-2.3M	124.00%106.4M	82.11%-11.2M	128.45%58.7M	-348.91%-79.9M	156.17%153.7M	141.52%47.5M
Investing cash flow
Cash flow from continuing investing activities	-104.03%-2.4M	-44.57%69.4M	-113.64%-3.9M	-103.04%-3.4M	473.91%17.2M	650.93%59.5M	-41.03%125.2M	350.88%28.6M	692.59%112M	-101.79%-4.6M
Net PPE purchase and sale	-106.96%-2.4M	262.67%24.4M	-178.57%-3.9M	-288.89%-3.4M	39.13%-2.8M	419.44%34.5M	70.93%-15M	87.72%-1.4M	114.29%1.8M	63.20%-4.6M
Net business purchase and sale	----	--0	--0	----	----	----	-59.22%110.2M	--0	--110.2M	----
Net other investing changes	----	50.00%45M	--0	--0	--20M	--25M	576.19%30M	----	----	----
Cash from discontinued investing activities
Investing cash flow	-104.03%-2.4M	-44.57%69.4M	-113.64%-3.9M	-103.04%-3.4M	473.91%17.2M	650.93%59.5M	-41.03%125.2M	350.88%28.6M	692.59%112M	-101.79%-4.6M
Financing cash flow
Cash flow from continuing financing activities	-2,750.00%-11.4M	28.11%-136.6M	-22,880.00%-113.9M	91.18%-15.9M	87.43%-6.4M	-100.98%-400K	64.53%-190M	-89.36%500K	-319.30%-180.3M	89.55%-50.9M
Net issuance payments of debt	----	45.21%-108.7M	---101.8M	96.44%-6.9M	--0	--0	63.49%-198.4M	--0	-352.21%-194M	90.83%-45.5M
Net common stock issuance	---9M	-367.74%-24.9M	---9.1M	-195.70%-8.9M	---6.9M	--0	10.71%9.3M	--0	--9.3M	----
Proceeds from stock option exercised by employees	300.00%400K	-85.23%2.2M	50.00%1.2M	-98.51%200K	0.00%700K	--100K	727.78%14.9M	60.00%800K	--13.4M	--700K
Net other financing activities	-460.00%-2.8M	67.09%-5.2M	-1,300.00%-4.2M	96.67%-300K	96.72%-200K	-25.00%-500K	-532.00%-15.8M	-200.00%-300K	-8,900.00%-9M	-2,950.00%-6.1M
Cash from discontinued financing activities
Financing cash flow	-2,750.00%-11.4M	28.11%-136.6M	-22,880.00%-113.9M	91.18%-15.9M	87.43%-6.4M	-100.98%-400K	64.53%-190M	-89.36%500K	-319.30%-180.3M	89.55%-50.9M
Net cash flow
Beginning cash position	98.01%209.1M	-5.46%105.6M	59.34%249.2M	281.69%271M	93.42%152.8M	-5.46%105.6M	-82.62%111.7M	78.13%156.4M	-19.86%71M	-81.64%79M
Current changes in cash	-199.37%-47.6M	1,795.08%103.4M	21.06%-40.1M	-125.29%-21.6M	1,565.00%117.2M	246.48%47.9M	98.85%-6.1M	-300.00%-50.8M	4,594.74%85.4M	97.67%-8M
Effect of exchange rate changes	--0	--100K	--0	---200K	--1M	---700K	--0	--0	--0	--0
End cash Position	5.69%161.5M	98.01%209.1M	98.01%209.1M	59.34%249.2M	281.69%271M	93.42%152.8M	-5.46%105.6M	-5.46%105.6M	78.13%156.4M	-19.86%71M
Free cash flow	-144.59%-36.2M	337.99%156.8M	190.44%73.8M	-103.85%-5.7M	141.26%103.5M	79.84%-14.8M	113.88%35.8M	-494.20%-81.6M	212.03%147.9M	133.81%42.9M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

According to the latest report from AXIOS, the US expects Iran to respond on several key issues within the next 48 hours. No agreement has b Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm